49616005: Monoclonal antibody (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Monoclonal antibody

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Monoclonal antibody	Is a	Non-organ specific antibody (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Monoclonal antibody	Is a	Antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Monoclonal antibody	Is a	Monoclonal immunoglobulin	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Monoclonal antibody	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gemtuzumab ozogamicin (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing infliximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing monoclonal antibody (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Abciximab (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing daclizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing basiliximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing etanercept (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Abciximab 10mg/5mL injection (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing trastuzumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Trastuzumab 150 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Mouse monoclonal antibody	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Muromonab-CD3 1mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Murine-human monoclonal IgG antibody (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Infliximab 100mg infusion concentrate (pdr for recon) (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Etanercept 25mg powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Abciximab 10mg/5 mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Etanercept 25mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Trastuzumab 440 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Daclizumab 25mg/5 mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Infliximab 100mg/vial injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing ibritumomab tiuxetan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Palivizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Rituximab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing alemtuzumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Alemtuzumab 30mg/3mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
anticorps monoclonal contre Escherichia coli	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Canine lymphoma monoclonal antibody	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing adalimumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Infliximab 100 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Omalizumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Efalizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Tositumomab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Daclizumab 25mg/5mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 20mg injection (pdr for recon)+solvent (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Basiliximab 10mg injection (pdr for recon)+solvent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
adalimumab 40mg injection solution 0.8mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Alemtuzumab 30mg/3mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Infliximab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Adalimunab 40mg/mL injection solution 1mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing cetuximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Cetuximab 2mg/mL injection solution 50mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing bevacizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Bevacizumab 25mg/mL injection solution 4mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Bevacizumab 25mg/mL injection solution 16mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing muromonab-CD3 (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Natalizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Etanercept 25mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Alemtuzumab 30mg/mL infusion concentrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
agent d'anticorps monoclonal	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Iodine (124-I) labeled monoclonal antibody (substance)	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Panitumumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Murine-human monoclonal IgG antibody (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Mouse monoclonal antibody	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing ustekinumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Belimumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Besilesomab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Brentuximab vedotin (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Alirocumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Idarucizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Necitumumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Daratumumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Blinatumomab (substance)	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Olaratumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Bezlotoxumab (substance)	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Dinutuximab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ixekizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Obiltoxaximab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Raxibacumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Brodalumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Avelumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ocrelizumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Dupilumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Muromonab-CD3 (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
anticorps monoclonal chimérique souris-humain d'isotype IgG	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Adalimumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Bevacizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ranibizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Eculizumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Zanolimumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Oregovomab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Certolizumab pegol	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Naptumomab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Golimumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ustekinumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Tocilizumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Denosumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Canakinumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Nivolumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Pertuzumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Vedolizumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Ramucirumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Siltuximab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Secukinumab	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Obinutuzumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Catumaxomab (substance)	Is a	False	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)
Elotuzumab (substance)	Is a	True	Monoclonal antibody	Inferred relationship	Existential restriction modifier (core metadata concept)

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
82640015	Monoclonal antibody	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
787314018	Monoclonal antibody (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3779819014	Monoclonal protein	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3779820015	Monoclonal immunoglobulin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
82640015	Monoclonal antibody	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
82640015	Monoclonal antibody	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
787314018	Monoclonal antibody (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
787314018	Monoclonal antibody (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3779819014	Monoclonal protein	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3779820015	Monoclonal immunoglobulin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core